Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Generic Health Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (166)
Cancellation by sponsor (126)
Prescription medicine registration (9)
Cancellation or suspension (7)
Australian public assessment report (AusPar) (1)
Listed medicine compliance report (1)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1)

Date

2026 (3)
2025 (13)
2024 (26)
2023 (23)
2022 (32)
2021 (15)
2020 (19)
2019 (23)
2018 (33)
2017 (17)
2016 (14)
2015 (10)
2014 (7)
2013 (13)
2012 (12)
2011 (17)
2010 (1)
2009 (6)
2008 (6)
2007 (16)
2006 (1)
2004 (2)
2001 (3)

Search

Sponsor content

312 result(s) found, displaying 31 to 40

RISPERIDONE GENERICHEALTH risperidone 4mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2024

Cancellation by sponsor

Requested by Generic Health Pty Ltd
RISPERIDONE GENERICHEALTH risperidone 2mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2024

Cancellation by sponsor

Requested by Generic Health Pty Ltd
RISPERIDONE GENERICHEALTH risperidone 3mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2024

Cancellation by sponsor

Requested by Generic Health Pty Ltd
RISPERIDONE GENERICHEALTH risperidone 1mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2024

Cancellation by sponsor

Requested by Generic Health Pty Ltd
TERIPARATIDE GH teriparatide 250 microgram per mL solution for injection pre-filled cartridge Cancelled under Section 30(1)(c) of the Act

28 June 2024

Cancellation by sponsor

Requested by Generic Health Pty Ltd
GABAPENTIN GENERICHEALTH gabapentin 300 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2024

Cancellation by sponsor

Requested by Generic Health Pty Ltd
GABAPENTIN GENERICHEALTH gabapentin 400 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2024

Cancellation by sponsor

Requested by Generic Health Pty Ltd
GABAPENTIN GENERICHEALTH gabapentin 100 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2024

Cancellation by sponsor

Requested by Generic Health Pty Ltd
TELMISARTAN HCT GH 80/25mg telmisartan 80mg and hydrochlorothiazide 25mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2024

Cancellation by sponsor

Requested by Generic Health Pty Ltd
CANDESARTAN GH candesartan cilexetil 32 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

28 June 2024

Cancellation by sponsor

Requested by Generic Health Pty Ltd

Pages

First page
Previous page
Page 1
Page 2
Page 3
Current page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.